Tech Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal Jonathan Jeriah November 16, 2022 1 min read Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal.Read More About The Author Jonathan Jeriah See author's posts Continue Reading Previous Previous post: ‘We’ve slotted him everywhere else and it hasn’t worked’: Why Huberdeau is on Flames 3rd lineNext Next post: Badenoch Calls for Green Investment to ‘Future-Proof’ UK Economy Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related News Why McLaren’s Headquarters Keeps Showing Up in Hit Movies Why McLaren’s Headquarters Keeps Showing Up in Hit Movies February 8, 2026 China-founded AI-agent start-up Manus acquired by Zuckerberg’s Meta for ‘billions’ China-founded AI-agent start-up Manus acquired by Zuckerberg’s Meta for ‘billions’ February 8, 2026